Scientists have developed revolutionary contact lenses that grant wearers the ability to see infrared light—a feat humans naturally cannot achieve. This breakthrough, detailed in the journal Cell00454 ...

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

W hen it comes to Love, Death + Robots, one can always count on the anthology series to crank out episodes that are equal ...

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces ...

New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces ...

Conduit both acquires and funds the development of Phase 2-ready assets, building an integrated and advanced platform-driven approach powered by artificial intelligence (AI) and cybernetics ... from ...

Virtus BBC ETF fell 9.74% to $17.15; SPDR XBI ETF dropped 6.63% to $77.17 on Tuesday. William Blair says Moderna faces increased scrutiny with mRNA vaccines under new CBER leadership. Get Matt ...

Are you exploring artificial intelligence in the life sciences? This event will feature a dynamic 45-minute panel discussion with leading UNC-Chapel Hill faculty innovators who have founded companies ...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor.

Meanwhile, Chicago-based MAIA Biotechnology has come up with a different kind of medicine to combat NSCLC. It has a number of clinical studies trialing its prized possession THIO. It is derived from ...